![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 2
2022
Gligorov, Joseph; Pivot, Xavier; Ataseven, Beyhan; De Laurentiis, Michelino; Jung, Kyung Hae; Manikhas, Alexey; Azim, Hamdy Abdel; Gupta, Kushagra; Alexandrou, Ari; Herraez-Baranda, Luis; Tosti, Nadia und Restuccia, Eleonora
(2022):
Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study.
In: Breast, Bd. 64: S. 151-158
Hurvitz, Sara A.; Bachelot, Thomas; Bianchini, Giampaolo; Harbeck, Nadia; Loi, Sherene; Park, Yeon Hee; Prat, Aleix; Gilham, Leslie; Boulet, Thomas; Gochitashvili, Nino; Monturus, Estefania; Lambertini, Chiara; Nyawira, Beatrice; Knott, Adam; Restuccia, Eleonora und Schmid, Peter
(2022):
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
In: Future Oncology, Bd. 18, Nr. 32: S. 3563-3572